HAIC of FOLFOX Clinical Trials

1 actively recruiting trial

No change since March 2026

Also known as: FOLFOX

Pipeline

Phase 2: 1

Top Sponsors

Tianjin Medical University Cancer Institute and Hospital1

Indications

Liver Disease1
Hepatocellular Carcinoma (HCC)1
Liver Cancer1
Cancer1

Other1 trial

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.